NYSEAMERICAN:ASXC Asensus Surgical (ASXC) Stock Price, News & Analysis $0.35 0.00 (0.00%) As of 08/22/2024 Add Compare Share Share Stock Analysis Stock Analysis About Asensus Surgical Stock (NYSEAMERICAN:ASXC) Get Asensus Surgical alerts:Sign Up Key Stats Today's Range$0.35▼$0.3550-Day Range$0.35▼$0.3552-Week Range$0.17▼$0.40VolumeN/AAverage Volume2.03 million shsMarket Capitalization$94.74 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Asensus Surgical, Inc. was a medical technology company focused on digital surgery and robotic-assisted minimally invasive procedures. The company developed technologies intended to give surgeons greater control and visualization while supporting more data-informed surgical care. Its products included the Senhance Surgical System, a robotic platform for laparoscopic surgery, and the Intelligent Surgical Unit, which added digital capabilities such as image enhancement and surgical data tools. Asensus was formerly known as TransEnterix and adopted the Asensus Surgical name in 2021. The company’s technologies were used in markets including the United States, Europe and Japan. In 2024, Asensus Surgical was acquired by German medical technology company KARL STORZ.AI Generated. May Contain Errors. Read More Receive ASXC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Asensus Surgical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ASXC Stock News HeadlinesAsensus Surgical Announces Closing of Acquisition by KARL STORZAugust 22, 2024 | globenewswire.comDurham public company staves off potential bankruptcy, will be acquiredAugust 21, 2024 | bizjournals.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 18 at 1:00 AM | Profits Run (Ad)Durham company could face bankruptcy if $95M sale failsAugust 15, 2024 | bizjournals.comBiggest stock movers today: NU, K, and moreAugust 14, 2024 | msn.comAsensus says it expects to file for bankruptcy if merger vote failsAugust 13, 2024 | msn.comAsensus Surgical, Inc. (ASXC) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | seekingalpha.comAsensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2024August 13, 2024 | finance.yahoo.comSee More Headlines ASXC Stock Analysis - Frequently Asked Questions How have ASXC shares performed this year? Asensus Surgical's stock was trading at $0.3479 at the start of the year. Since then, ASXC shares have increased by 0.0% and is now trading at $0.3479. How were Asensus Surgical's earnings last quarter? Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) posted its quarterly earnings results on Wednesday, November, 3rd. The company reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.01. The business earned $2.57 million during the quarter, compared to analysts' expectations of $1.02 million. Asensus Surgical had a negative trailing twelve-month return on equity of 184.10% and a negative net margin of 902.25%. What other stocks do shareholders of Asensus Surgical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Asensus Surgical investors own include Bionano Genomics (BNGO), Tesla (TSLA), NIO (NIO), Palantir Technologies (PLTR), Senseonics (SENS), SNDL (SNDL) and Advanced Micro Devices (AMD). Company Calendar Today11/18/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSEAMERICAN:ASXC CIKN/A Webwww.asensus.com Phone(919) 765-8400Fax919-765-8459Employees170Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.31) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$78.43 million Net Margins-902.25% Pretax Margin-899.16% Return on Equity-184.10% Return on Assets-114.75% Debt Debt-to-Equity RatioN/A Current Ratio1.00 Quick Ratio0.69 Sales & Book Value Annual Sales$8.58 million Price / Sales11.04 Cash FlowN/A Price / Cash FlowN/A Book Value$0.13 per share Price / Book2.68Miscellaneous Outstanding Shares272,330,000Free Float264,516,000Market Cap$94.74 million OptionableNot Optionable Beta1.37 Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSEAMERICAN:ASXC) was last updated on 8/22/2024 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredEarly bird access on this Black Friday dealMarkham Trading's Alpha Oracle Signal system is just $7 for Black Friday. Others paid nearly $2,000 for access...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Asensus Surgical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Asensus Surgical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.